# Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis

> **NCT04115020** · PHASE2 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Osteoarthritis
- Arthritis, Rheumatoid
- Arthritis, Psoriatic

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04115020
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01
- **Primary completion:** 2020-01-07
- **Final completion:** 2020-01-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** A pilot study was negative.
- **Last updated:** 2020-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04115020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04115020, "Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04115020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*